<DOC>
	<DOCNO>NCT01769781</DOCNO>
	<brief_summary>The aromatase inhibitor ( anastrazole ) plus long acting GnRH agonist leuprolide acetate test treatment woman endometriosis recurrence compare classical GnRH analog treatment . Pain symptom disappearance disease free time follow-up outcome establish medical treatment best endometriosis recurrence treatment .</brief_summary>
	<brief_title>Anastrazole Plus GnRH-agonist Treatment Endometriosis Recurrence</brief_title>
	<detailed_description>Endometriosis chronic disease affect 5-10 % woman reproductive age , show recurrence surgery least 20-50 % 5 year follow-up . Aromatase inhibitor plus GnRH analog may effective GnRH agonist alone treatment endometriosis recurrence .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>woman affect endometriosis show recurrence pain symptom , previous surgery endometriosis presence systemic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>endometriosis recurrence</keyword>
	<keyword>pelvic pain</keyword>
	<keyword>aromatase inhibitor</keyword>
</DOC>